Background illustration for clinical trials search

Migraine Clinical Trials

Browse 180 migraine clinical trials enrolling across the United States and Canada. 52 people applied to migraine studies last month. Search by city or state to find one near you.

Filter
1
FeaturedActive & Responsive

Migraine Prevention Studies for Adults With 2–10 Moderate-to-Severe Attacks a Month

for
Migraine Disorders
Location: East Greenwich RI, Hallandale FL, Savannah GA,

Sex: All

Age: 18 - 70+

Recruiting
Active & Responsive

Responding With Evidence and Access for Childhood Headaches

for
Headache, Headache Disorders, Headache, Migraine, Migraine,
Location: Philadelphia PA, Wilmington DE, Amherst NY,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 10 - 17

Code: NCT05889624

Recruiting
Active & Responsive

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

for
Chronic Pain, Acute Pain, Post Operative Pain,
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT05754190

Recruiting
Active & Responsive

Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

for
Chronic Daily Headache, Chronic Migraine
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT03231241

Recruiting
Active & Responsive

Effects of a Multispecies Probiotic on Migraine

for
Migraine, Irritable Bowel Syndrome, Headache, Migraine
Location: La Jolla CA
Sponsor: Scripps Health

Sex: All

Age: 18 - 70+

Code: NCT04696458

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine

for
Migraine Disorders, Chronic Migraine Headache, Migraine
Location: Tacoma WA
Sponsor: Cortex Neurovascular

Sex: All

Age: 18 - 64

Code: NCT07652034

Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

for
Preventive Treatment of Migraine
Location: Boca Raton FL, Winter Park FL, Ann Arbor MI,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07729462

Phase 3, Recruiting
Active & Responsive

Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

for
Visual Snow Syndrome, Migraine, Healthy
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18 - 60

Code: NCT06961864

Recruiting
Active & Responsive

Mechanistic Studies of Psilocybin in Headache Disorders

for
Migraine
Location: West Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 70

Code: NCT06464367

Early Phase 1, Recruiting
Active & Responsive

Light Exposure, Migraine Outcomes, and Sleep Quality

for
Migraine Headache, Sleep, Photophobia
Location: Tempe AZ
Sponsor: Arizona State University

Sex: All

Age: 18+

Code: NCT07476053

Recruiting
Active & Responsive

Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

for
Migraine
Location: Phoenix AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06401642

Recruiting
Active & Responsive

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

for
Chronic Migraine
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 18 - 65

Code: NCT05769348

Recruiting
Active & Responsive

A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine

for
Resistant Migraine, Chronic Migraine Headache,
Location: Olney MD, Charlotte NC, Newnan GA
Sponsor: Salvia BioElectronics

Sex: All

Age: 22 - 70+

Code: NCT07719608

Recruiting
Active & Responsive

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

for
Migraine
Location: Hyde Park MA, Providence RI, Manhasset NY, New York NY,
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70

Code: NCT06972056

Phase 4, Recruiting
Active & Responsive

Study of EVO756 in Adults With Migraine

for
Migraine
Location: Westborough MA, Foxborough MA, New Haven CT, Quebec,
Sponsor: Evommune, Inc.

Sex: All

Age: 18 - 64

Code: NCT07616128

Phase 2, Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

for
Menstrual Migraine
Location: Halifax, East Greenwich RI, Levis, The Bronx NY,
Sponsor: Pfizer

Sex: Female

Age: 18 - 45

Code: NCT06641466

Phase 3, Recruiting
Active & ResponsiveNew

Dietary Intervention for Migraine Relief

for
Migraine
Location: Washington D.C. DC
Sponsor: American University

Sex: All

Age: 18 - 70+

Code: NCT07360405

Recruiting
Active & Responsive

Overlapping Pain Trajectory Study

for
Migraine, Musculoskeletal Pain,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 10 - 19

Code: NCT05752396

Recruiting
Active & Responsive

Efficacy of Nerve Blocks for Episodic Migraine

for
Episodic Migraine
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05734625

Phase 2, Recruiting
Active & Responsive

Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

for
Migraine, Traumatic Brain Injury, Anomalous Health Incidents
Location: Bethesda MD
Sponsor: Uniformed Services University of the Health Sciences

Sex: All

Age: 18+

Code: NCT07267819

Recruiting

What is migraine?

Migraine is a brain condition, not a blood vessel problem or a stress reaction. An attack usually brings throbbing pain on one side of the head, along with nausea and sensitivity to light and sound, and it can last from a few hours to three days. About 1 in 4 people with migraine get an aura first, visual disturbances like flashing lights or zigzag lines that come before the pain. Doctors sort migraine by frequency: episodic means fewer than 15 headache days a month, chronic means 15 or more, with at least 8 of them migraine days, for more than three months.

For most of medical history, migraine was treated with medicines borrowed from other conditions: blood pressure pills, antidepressants, epilepsy drugs. That changed in 2018, when the first medicine designed specifically for migraine was approved. It blocks a molecule called CGRP, which the brain releases during an attack. There are now four CGRP antibodies given by injection and several CGRP blocking pills, called gepants, and they treat both attacks and prevention. In a 2025 real world study of more than 2,000 patients, about 47 percent of people on a CGRP antibody had a meaningful response at three months, compared with about 35 percent on traditional preventives.

Types of migraine clinical trials

Who can participate in migraine clinical trials?

Episodic and chronic migraine, and why the line matters for trials

Do migraine trial participants get paid?

What is the difference between a migraine and a headache?

How to Enroll in a Clinical Trial for Migraine